Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023241 (
Legionella
)
6,990
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The human pathogen
Legionella
pneumophila
must evade host cell death signaling to enable replication in lung macrophages and to cause disease. After bacterial growth, however,
L. pneumophila
is thought to induce apoptosis during egress from macrophages. The bacterial effector protein, SidF, has been shown to control host cell survival and death by inhibiting pro-apoptotic BNIP3 and
BCL-RAMBO
signaling. Using live-cell imaging to follow the
L. pneumophila
-macrophage interaction, we now demonstrate that
L. pneumophila
evades host cell apoptosis independent of SidF. In the absence of SidF,
L. pneumophila
was able to replicate, cause loss of mitochondria membrane potential, kill macrophages, and establish infections in lungs of mice. Consistent with this, deletion of BNIP3 and
BCL-RAMBO
did not affect intracellular
L. pneumophila
replication, macrophage death rates, and
in vivo
bacterial virulence. Abrogating mitochondrial cell death by genetic deletion of the effectors of intrinsic apoptosis, BAX, and BAK, or the regulator of mitochondrial permeability transition pore formation, cyclophilin-D, did not affect bacterial growth or the initial killing of macrophages. Loss of BAX and BAK only marginally limited the ability of
L. pneumophila
to efficiently kill all macrophages over extended periods.
L. pneumophila
induced killing of macrophages was delayed in the absence of capsase-11 mediated pyroptosis. Together, our data demonstrate that
L. pneumophila
evades host cell death responses independently of SidF during replication and can induce pyroptosis to kill macrophages in a timely manner.
...
PMID:
Legionella pneumophila
Strain 130b Evades Macrophage Cell Death Independent of the Effector SidF in the Absence of Flagellin. 2826 64